Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricBNTXBiontech SEINCYIncyteMRNAModerna
Snapshot
Price$96.64$115.06$188.54
Market cap$24.67B$23.35B$31.65B
Valuation
P/E—16.1x—
Forward P/E—11.5x—
Growth
Revenue growth-11.8%21.5%-30.0%
EPS growth—2455.3%—
Profitability
Net margin-34.0%26.7%-143.6%
ROE-6.7%29.2%-36.7%
Balance sheet & cash
Debt / equity0.01x0.01x0.07x
Free cash flow yield13.6%2.2%-13.6%
Dividend yield———
Verdict
Investment ratingWeak· 31Strong· 86Weak· 17

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearBNTXtoday $97INCYtoday $115MRNAtoday $189
2027$73.93 – $108.43+12% CAGR$2,205.10 – $3,234.15+2711% CAGR$144.23 – $211.54+12% CAGR
2028$75.41 – $110.60+7% CAGR$56,347.26 – $82,642.65+2580% CAGR$147.12 – $215.77+7% CAGR
2029$76.92 – $112.81+5% CAGR$1,439,847.23 – $2,111,775.94+2538% CAGR$150.06 – $220.09+5% CAGR
2030$78.45 – $115.07+4% CAGR$36,792,560.38 – $53,962,421.89+2517% CAGR$153.06 – $224.49+4% CAGR
2031$80.02 – $117.37+4% CAGR$940,163,974.57 – $1,378,907,162.71+2504% CAGR$156.12 – $228.98+4% CAGR
5-yr CAGR-3.7% – 4.0%2312.4% – 2504.5%-3.7% – 4.0%